StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-1.00%)

Close on Nov 18, 2026Market cap $452.45KP/E –Yield –

Arcadia Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Arcadia Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$3.80M. For fiscal 2025 it was -$2.50M. The highest annual figure on record is -$2.50M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.50M–
FY2024Dec 31, 2024-$3.65M–
FY2023Dec 31, 2023-$6.10M–
FY2022Dec 31, 2022-$14.01M–
FY2021Dec 31, 2021-$35.53M–
FY2020Dec 31, 2020-$12.78M–
FY2019Dec 31, 2019-$19.38M–
FY2018Dec 31, 2018-$16.87M–
FY2017Dec 31, 2017-$14.32M–
FY2016Dec 31, 2016-$18.62M–
FY2015Dec 31, 2015-$15.56M–
FY2014Dec 31, 2014-$15.15M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$496.00K–
Q1 FY2026Mar 31, 2026-$779.00K-247.0%
Q4 FY2025Dec 31, 2025-$1.38M–
Q3 FY2025Sep 30, 2025-$1.15M–
Q2 FY2025Jun 30, 2025-$501.00K-125.3%
Q1 FY2025Mar 31, 2025$530.00K–
Q4 FY2024Dec 31, 2024-$2.28M–
Q3 FY2024Sep 30, 2024-$1.76M–
Q2 FY2024Jun 30, 2024$1.98M–
Q1 FY2024Mar 31, 2024-$1.59M–
Q4 FY2023Dec 31, 2023-$1.19M–
Q3 FY2023Sep 30, 2023-$1.40M–
Q2 FY2023Jun 30, 2023-$1.45M–
Q1 FY2023Mar 31, 2023-$3.87M–
Q4 FY2022Dec 31, 2022-$4.66M–
Q3 FY2022Sep 30, 2022-$3.99M–
Q2 FY2022Jun 30, 2022-$3.78M–
Q1 FY2022Mar 31, 2022-$4.62M–
Q4 FY2021Dec 31, 2021-$13.80M-284.8%
Q3 FY2021Sep 30, 2021-$8.71M–
Q2 FY2021Jun 30, 2021-$7.68M–
Q1 FY2021Mar 31, 2021-$5.33M–
Q4 FY2020Dec 31, 2020$7.47M–
Q3 FY2020Sep 30, 2020-$7.58M–
Q2 FY2020Jun 30, 2020-$6.88M–
Q1 FY2020Mar 31, 2020-$5.79M–
Q4 FY2019Dec 31, 2019-$3.99M–
Q3 FY2019Sep 30, 2019-$6.19M–
Q2 FY2019Jun 30, 2019-$4.98M–
Q1 FY2019Mar 31, 2019-$4.22M–
Q4 FY2018Dec 31, 2018-$4.35M–
Q3 FY2018Sep 30, 2018-$4.10M–
Q2 FY2018Jun 30, 2018-$4.58M–
Q1 FY2018Mar 31, 2018-$3.84M–
Q4 FY2017Dec 31, 2017-$3.00M–
Q3 FY2017Sep 30, 2017-$3.62M–
Q2 FY2017Jun 30, 2017-$3.74M–
Q1 FY2017Mar 31, 2017-$3.96M–
Q4 FY2016Dec 31, 2016-$5.47M–
Q3 FY2016Sep 30, 2016-$3.93M–

More Arcadia Biosciences figures

See a number that looks wrong?